Testicular

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
30982
Carboplatin in the adjuvant treatment of stage I Seminoma
30948
A Phase II trial of C-BOP/BEP intensive induction chemotherapy for intermediate and poor prognosis metastatic germ cell tumors.
30942
A randomised Prospective Comparison of Two Schedules of Radiotherapy for Stage 1 Seminoma Testis Following Orchidectomy
30941
A randomized phase III study of 3 BEP versus 3 BEP-1 EP, and the 5-day schedule versus 3 days per cycle in good prognosis germ cell cancer
30896
Phase III study of BEP versus CEB in the management of good prognosis metastatic testicular (and extragonadal) teratoma (MRC/EORTC Collaborative Study)
30895
Phase III study of BEP versus BOP/VIP in the management of poor prognosis metastatic testicular and extragonadal teratoma (MRC/EORTC Collaborative Study)
16881
Phase II study of high dose epirubicin in patients with progressive measurable metastatic non seminomatous germ cell tumors, including extragonadal tumors. (jointly with the EORTC Genito-Urinary Tract Cancer Cooperative Group - Protocol 30883)
30874
Phase II study of cisplatin combination chemotherapy in high risk metastatic seminoma
30873
A randomized phase III study of BEP (bleomycin, etoposide (VP-16), cisplatin) versus VIP (VP-16, ifosfamide, cisplatin) in intermediate risk patients with disseminated non-seminomatous testicular cancer
30871
Phase II Chemotherapy with 5-Aza-2'-deoxycytidine in Patients with Nonseminomatous Testicular or Extragonadal Germ Cell Tumors That Are Progressive, Measurable, and Metastatic (Summary Last Modified 05/88)
16851E
Phase II trial of 5-aza 2'-deoxycytidine in testicular cancer
30824
Phase III trial for induction chemotherapy regimens (PVB-BEP-EP) in non pretreated patients stratified for high versus low volume metastases of non seminomatous testicular cancer
30974
A ranomized phase III study of sequential high-dose Cisplatinum/Etoposide/Ifosfamide plus stem cell support versus BEP in patients with poor prognosis Germ Cell Cancer
30883
Phase II study of high dose epirubicin in patients with progressive measurable metastatic non seminomatous germ cell tumours, including extragonadal tumours. (Jointly with the EORTC Early Clinical trials Cooperative Group - Protocol 16881)
30847
Phase II protocol to study management of stage I non-seminomatous testicular cancer with unilateral orchidectomy alone
30983
Randomized phase II/III study of Taxol-BEP versus BEP in patients with intermediate prognosis germ cell cancer

Back to Site-list